Biosion
Kedan Lin is an accomplished pharmaceutical professional with extensive experience in clinical development and operations. Currently serving as Chief Development Officer at Biosion since February 2025, Kedan previously worked as an independent consultant from July 2024 to March 2025 and held the position of Senior Vice President of US Operations at HARBOUR BIOMED from August 2022 to July 2024. Prior roles include Senior Vice President and Vice President of Clinical Development and US Operations at Innovent Biologics from August 2018 to October 2022, and Director of Clinical Pharmacology at NGM Biopharmaceuticals from May 2016 to August 2018. Kedan Lin holds a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco, earned in January 2000.
This person is not in any teams
This person is not in any offices